https://www.thebodypro.com/category/adverse-events-comorbidities-hiv/tag/hepatitis-c

The Latest

hole in a fence

This Week in HIV Research: Removing Barriers to Better Care

Oct. 31, 2019: HCV treatment efficacy regardless of injection drug use; chronic pain, marijuana, and prescription opoids; the most urgent HIV training priorities; neuro effects of switching from Atripla to Complera.

Jail Cell Door And Welded Iron Bars

Getting Hepatitis C Treatment to People in Jails Isn’t Easy. Here Are Some Recommendations.

People in jail, who are often in the system for less time than those in prison, often receive little to no hepatitis C screening or treatment. One provider works to change this in Massachusetts.

Various Road Closed signs

Test-and-Treat for Hepatitis C: What Are the Obstacles?

A series of studies aim to determine whether test-and-treat strategies can be implemented for people with hepatitis C, much like programs for people living with HIV.

close up of man's arm getting blood drawn

We Have a Cure for Hepatitis C. Why Are Rates So High?

An in-depth update on what we know about HCV risk, symptoms, screening, outcomes, and treatment (including financial barriers).

broken heart with zig-zag thread holding it together embroidery

This Week in HIV Research: My Achy-Breaky Heart

Sep. 5, 2019: An extra decade of "heart age"; stop grouping trans women with MSM; women often have anal cancer precursor lesions; hep C treatment success doesn't equal more risk behavior.

hepatitis word cloud

Trends in Deaths Among People With Hepatitis C Virus in British Columbia

A new study puts numbers to increasingly divergent trends in liver-related deaths vs. injection-related deaths in recent years, highlighting both the success of modern HCV treatment and the devastating effects of the opioid crisis.

pharmacist looking at list

Hepatitis C (HCV) Initial Treatment Recommendations: A Closer Look at the Options

Although several HCV drugs can cure almost all infections regardless of viral genotype, picking the right drug will depend on each patient's medical history, level of liver damage, and coinfections.

couple on the boardwalk surrounded by seagulls

This Week in HIV Research: When STIs Flock Together

July 18, 2019: Anal neoplasia risk amidst comorbid HPV and chlamydia; predictive modeling for PrEP outreach; long-term benefits of hepatitis C cure in coinfection; first-line therapy with dolutegravir/lamivudine.

Hepatitis C virion

Underwhelming Results From Hepatitis C Vaccine Trial

The 548-person U.S. study found that chronic hepatitis C infection occurred among an identical number of people who received the experimental vaccine compared to people who received a placebo.

Close up of sneakers walking up stairs

This Week in HIV Research: One Step at a Time

June 13, 2019: Integrated stepped alcohol treatment in HIV clinics; cytokines, inflammation, and heart risk; impact of CCR5 gene editing on lifespan; the costs of "test and treat" for hepatitis C.